Disclosed is a medical device for use during sexual intercourse for a female who has underwent a hysterectomy. The medical device includes a flexible body and a ring for insertion and removal. The device is utilized to relieve lower back and leg pain during a performance of sexual intercourse.

Disclosed is a medical device for use during sexual intercourse for a female who has underwent a hysterectomy. The medical device includes a flexible body and a ring for insertion and removal. The device is utilized to relieve lower back and leg pain during a performance of sexual intercourse.

A device sized and shaped for alleviating pelvic organ prolapse when inserted into a vagina, comprising: a treatment rendering portion configured to be adjustable between a first, collapsed state and a second, expanded state, where the second expanded state extends substantially in three dimensions.

A device sized and shaped for alleviating pelvic organ prolapse when inserted into a vagina, comprising: a treatment rendering portion configured to be adjustable between a first, collapsed state and a second, expanded state, where the second expanded state extends substantially in three dimensions.

The invention provides methods for the treatment of vaginal laxity which include delivering a cell-containing composition to the vagina. The composition can include fat tissue to provide a bulking effect to reduce the size of the vaginal opening. The cells can provide healing and revascularization of the vaginal treatment area to sustain the bulking provided by the fat. The invention also provides systems and compositions useful for performing the method, and can include instruments and devices for removal of autologous adipose tissue from a patient (e.g., by liposuction), equipment for the enrichment of cells from adipose tissue, mechanical processing of adipose tissue, and the mixing of cells and processed adipose tissue. Devices for the delivery of the cell compositions to the vagina can also be included in the system.

Vaginal device (1) for pelvic organ prolapse treatment, having an elongated base element (2), an inflatable element (3) attached to a distal end part (2a) of the elongated base element (2), and a support element (4) attached to a proximal end part (2b) of the elongated base element (3). The support element (4) has at least two support members (5), which extend away from the proximal end (2b) of the elongated base element (2). The at least two support elements (5) are arranged to support lower parts of prolapsed compartments, and the support element (4) comprises an adjustable connector for fixing the position of the support element (4) along the proximal end part (2b) of the elongated base element (3).

Vaginal device (1) for pelvic organ prolapse treatment, having an elongated base element (2), an inflatable element (3) attached to a distal end part (2a) of the elongated base element (2), and a support element (4) attached to a proximal end part (2b) of the elongated base element (3). The support element (4) has at least two support members (5), which extend away from the proximal end (2b) of the elongated base element (2). The at least two support elements (5) are arranged to support lower parts of prolapsed compartments, and the support element (4) comprises an adjustable connector for fixing the position of the support element (4) along the proximal end part (2b) of the elongated base element (3).

A vaginal insert device and method of use for improving and preventing symptoms associated with pelvic organ prolapse and urinary and/or fecal incontinence, administer medication or topical treatment, and/or collect a sample when the device is inserted, or any combination thereof. The vaginal insert device may be cone-shaped, may have a removal portion, may have external ridges, may have internal ribs, may have an open or closed top, or combinations thereof. The device may include cavities, diagnostic devices, and/or microchips.

A vaginal insert device and method of use for improving and preventing symptoms associated with pelvic organ prolapse and urinary and/or fecal incontinence, administer medication or topical treatment, and/or collect a sample when the device is inserted, or any combination thereof. The vaginal insert device may be cone-shaped, may have a removal portion, may have external ridges, may have internal ribs, may have an open or closed top, or combinations thereof. The device may include cavities, diagnostic devices, and/or microchips.

Compositions and methods for inhibiting and interrupting biofilm formation, and for destabilizing established biofilms are provided, the novel compositions including polymeric resins and monomeric non-polymerizable and polymerizable resins. More particularly, the compositions and methods enable the protection and removal of biofilms from surfaces in the context of medical, consumer, domestic, food service, environmental and industrial applications, where the effects constitute beneficial and desirable biofilm attenuating activity.